Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


AFT Pharmaceuticals considers IPO, listing on NZX and ASX

AFT Pharmaceuticals considers IPO, listing on NZX and ASX

By Sophie Boot

Nov. 17 (BusinessDesk) - AFT Pharmaceuticals, the Auckland-based pharmaceutical company, is considering a $49 million initial public offering along with listing on the NZX and ASX.

The proposed offer involves a primary raise of $45 million, and a $4 million selldown by the Atkinson Family Trust, which owns 87 percent of the company.

AFT, which was founded in 1997, made a loss of $12.9 million for the year ended March 31, on revenue of $56.2 million. The company has achieved a compound annual growth rate in operating revenue of 21 percent over the past 10 years. It made a loss of $6.4 million for the six months ending Sept. 30, compared to a $6.1 million loss for the same period a year earlier, but improved revenue to $29.5 million from $24.2 million.

The company wants to continue introducing new products to the New Zealand, Australian and South East Asian markets, and expand its products internationally through third-party licensees and distributors. Half of AFT's 2015 revenue was from New Zealand, 47 percent from Australia and the remainder from the rest of the world, primarily South East Asia where the company began selling in mid-2014. The company sells 109 products across Australia and New Zealand, and had entered outlicensing or distribution agreements in over 35 countries for one or more of its products.

“We believe that our business is set up to perform well on the world stage,” said Dr Hartley Atkinson, chief executive and founder of AFT. “In terms of product development, regulatory approvals, licensing and distribution, we’ve developed a good track record. Raising new capital is really about taking this business to the next level and advancing our portfolio of innovative development products."


© Scoop Media

Business Headlines | Sci-Tech Headlines


Forest And Bird: Misinformation Circulating On Biodiversity Policy

Forest & Bird is concerned at misinformation circulating regarding a policy statement aimed at protecting New Zealand’s unique biodiversity. The National Policy Statement for Indigenous Biodiversity is being consulted on by the ... More>>


NIWA: Scientists Say Methane Emitted By Humans ‘vastly Underestimated’

NIWA researchers have helped unlock information trapped in ancient air samples from Greenland and Antarctica that shows the amount of methane humans are emitting into the atmosphere from fossil fuels has been vastly underestimated... More>>


SMC Expert Reaction: Record Dry Spells And Effects On Forests

With no rain forecast before Sunday, Auckland is about to break a record for the city's longest dry spell. Niwa says Auckland is likely to hit 40 consecutive days without rain this weekend . The upper North Island is seeing severe meterological ... More>>


Reserve Bank: Official Cash Rate Remains At 1.0 Percent

The Monetary Policy Committee has decided to keep the Official Cash Rate (OCR) at 1.0 percent. Employment is at or slightly above its maximum sustainable level while consumer price inflation is close to the 2 percent mid-point of our target range. ... More>>


Science Media Centre: Novel Coronavirus Detected In China – Expert Reaction

The virus was detected after more than 40 people were hospitalised with pneumonia in Wuhan City, China and the outbreak traced to a large animal and seafood market. The Centers for Disease Control and Prevention reports that person-to-person transmission ... More>>


NZ First: Launch Of Parliament Petition To Remove Aluminium Dross

This afternoon to a crowd of over 100 people in Mataura -- Mark Patterson, New Zealand First List MP based in Clutha-Southland launched a parliamentary petition regarding the aluminium dross issue in Mataura, Southland. The petition asks that the House ... More>>